Betsy A. Dusak - Concepedia

Author

Betsy A. Dusak

Also Known As

B A Dusak, B Dusak, B. A. DUSAK, B. A. Dusak, B. Dusak, BETSY DUSAK, Betsy A Dusak, Betsy A. Dusak, Betsy Dusak, Betsy A. Dusak

Publications

654

Citations

H-Index

Concepts

All Affiliations

DuPont (United States)

About

Betsy A. Dusak is an author at DuPont (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	512
2	Natural Sciences	1	1	104
3	Public Health	1	1	123
4	Biochemistry	1	1	104
5	Biomolecular Engineering	1	1	261

Betsy A. Dusak

Publications

641

Citations

H-Index

Page 1

	Year	Citations
Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization Jack B. Jiang, David P. Hesson, Betsy A. Dusak, Journal of Medicinal Chemistry Tumor BiologyMedicinal ChemistryAntimitotic Anticancer AgentsChemoprevention StrategyMedicine	1990	261
Immune Thrombocytopenic Purpura and Pregnancy Douglas B. Cines, Betsy A. Dusak, Ann Tomaski, New England Journal of Medicine Antiplatelet AntibodyImmunologyGynecologyImmune Thrombocytopenic PurpuraHigh-risk Pregnancy	1982	123
Effects of Modulation of Basic Fibroblast Growth Factor on Tumor Growth In Vivo Janet L. Gross, William F. Herblin, Betsy A. Dusak, JNCI Journal of the National Cancer Institute	1993	105
Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors. Daniel L. Dexter, David P. Hesson, Robert Ardecky, PubMed Molecular PharmacologyMedicinal ChemistryNovel 4-Quinolinecarboxylic AcidExperimental TumorsL1210 Leukemia	1985	104
Granulocyte-associated IgG in neutropenic disorders. Douglas B. Cines, Frank Passero, DuPont Guerry, PubMed	1982	24
Cytotoxicity of synthetic racemic ptilocaulin: A novel cyclic guanidine Regina L. Ruben, Barry B. Snider, Frank W. Hobbs, Investigational New Drugs MedicineNovel Cyclic GuanidineSelective ToxicityToxicologyPharmacology	1989	12
Once‐Daily Quadruple‐Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment‐Naive Human Immunodeficiency Virus Type 1–Infected Patients Gail Skowron, Daniel R. Kuritzkes, Melanie Thompson, The Journal of Infectious Diseases Hiv-1 Rna48-Week Open-label StudyMedicineHuman RetrovirusImmunology	2002	12

Page 1